论文部分内容阅读
肝素钙的近几年才研制的新产品。它的抗肾素、抗醛固酮活性优于肝素钠。皮下注射不改变血管致密性,不减少细胞间毛细血管的钙胶质,克服了肝素钠皮下注射引起出血的付作用。因此肝素钙可能成为肝素钠的换代制剂。方法与资料一、病例选择:1991年6月～1992年11月急诊科住院的冠心病患者。年龄40～70岁,治疗组25例、对照组25例。各组男13例、女12例、共50例。
Heparin calcium in recent years developed a new product. Its anti-renin, anti-aldosterone activity is superior to heparin sodium. Subcutaneous injection does not change vascular densification, does not reduce the intracellular calcium in the capillaries, to overcome the heparin subcutaneous injection of bleeding caused by the role of pay. Therefore heparin calcium heparin sodium may become a replacement agent. Methods and data A case selection: June 1991 ~ November 1992 emergency department hospitalized patients with coronary heart disease. Aged 40 to 70 years old, 25 cases in the treatment group and 25 cases in the control group. Each group of 13 males and 12 females, a total of 50 cases.